ArticleDermatology and therapy2026

Use of Ruxolitinib Cream Results in Economic Benefits Compared with Dupilumab in Treatment of Patients with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy.

Omar Noor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.